Aphro Pharma Private Limited
About Aphro Pharma Private Limited
Data last updated:
Aphro Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC216480. Its GSTIN is 07AAJCA6648J1ZA (Delhi).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Sahil Bathla and Isha Dhall.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – Lg – 2 F – 27 Madhu Vihar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.89 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net loss of ₹76,837 (net margin -6.5%) and EBITDA of ₹54,392 (EBITDA margin 4.6%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹9.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No – Lg – 2 F – 27 Madhu Vihar, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aphro Pharma Private Limited
The main business activity of Aphro Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aphro Pharma Private Limited FY 2025 filings available
Aphro Pharma Private Limited reported revenue of ₹11.89 Lakh (down 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aphro Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 24% fall in the latest year. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aphro Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹54,392 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹76,837 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aphro Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -6.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aphro Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aphro Pharma Private Limited
Aphro Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zemlin Healthcare Private Limited | ₹11.97 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Copan India Private Limited | ₹11.96 Lakh (FY 2025) | •••• | •••• | •••• | Bhiwandi, Maharashtra, India | |
| Zahracure Exim Private Limited | ₹11.94 Lakh (FY 2025) | •••• | •••• | -94.0% | •••• | Ahmedabad, Gujarat, India |
| Kirti Merchantile Private Limited | ₹11.93 Lakh (FY 2025) | •••• | •••• | 30.0% | •••• | Mumbai, Maharashtra, India |
| Medisage Health Private Limited | ₹11.91 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Aphro Pharma Private Limited this company | ₹11.89 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Delhi, India |
| Allishan Biotech Private Limited | ₹11.86 Lakh (FY 2025) | •••• | •••• | 268.0% | •••• | Bhubaneswar, Odisha, India |
| Nach Formulations Private Limited | ₹11.85 Lakh (FY 2023) | •••• | •••• | 154.0% | •••• | Secunderabad, Telangana, India |
| JGP Pharmaceutical Private Limited | ₹11.84 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Vitco Lab and Healthcare Private Limited | ₹11.8 Lakh (FY 2025) | •••• | •••• | 282.0% | •••• | Ambala, Haryana, India |
| Ur Biocoction Private Limited | ₹11.77 Lakh (FY 2018) | •••• | •••• | -49.0% | •••• | Barasat, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Aphro Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aphro Pharma Private Limited
Aphro Pharma Private Limited is audited by KARAN CHHABRA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KARAN CHHABRA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aphro Pharma Private Limited
Aphro Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sahil Bathla | Director | 01 May 2016 | 10 Years 5 Months | Current |
| Isha Dhall | Director | 01 Sep 2014 | 12 Years 1 Months | Current |
| Mukesh Dhall | Director | 24 Mar 2011 | 15 Years 6 Months | Current |
Ownership and Shareholding of Aphro Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aphro Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2024 | Others | ₹9.5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Aphro Pharma Private Limited
Employment history and EPFO contributions of people linked to Aphro Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aphro Pharma Private Limited
Aphro Pharma Private Limited has 7 board changes on record since 2011: 5 appointments and 2 cessations. The latest: Sahil Bathla was appointed as Director on 01 May 2016.
Credit Ratings, Litigation & Regulatory Alerts for Aphro Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aphro Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aphro Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aphro Pharma Private Limited
Aphro Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCA6648J1ZA | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aphro Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aphro Pharma Private Limited
Aphro Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 March 2011 (15+ years old) and is registered under CIN U24232DL2011PTC216480.
Aphro Pharma reported revenue of ₹11.89 Lakh for FY 2025 (down 24% YoY).
Aphro Pharma has 3 current directors:
- Sahil Bathla - Director
- Isha Dhall - Director
- Mukesh Dhall - Director
Aphro Pharma reported a net loss of ₹76,837 (net margin -6.5%) and EBITDA of ₹54,392 (EBITDA margin 4.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aphro Pharma is -8% over three years and -11% over five years. In the latest year (FY 2025) revenue fell 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aphro Pharma is 07AAJCA6648J1ZA, registered in Delhi.
The CIN (Corporate Identification Number) of Aphro Pharma is U24232DL2011PTC216480. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aphro Pharma was incorporated on 24 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aphro Pharma by revenue are Zemlin Healthcare Private Limited, Copan India Private Limited, Zahracure Exim Private Limited, Kirti Merchantile Private Limited, Medisage Health Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Sahil Bathla was appointed as Director on 01 May 2016. Kanwal Rattan ceased to be Director on 15 Sep 2014. Rajiv Dhaor ceased to be Director on 15 Sep 2014. Aphro Pharma has 7 board changes on record in total.
The registered office of Aphro Pharma is at Shop No – Lg – 2 F – 27 Madhu Vihar, Delhi, India – 110092.